[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"NeuroTrainer\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100555506",false,"NCT06512974","NeuroTrainer Cognitive Training For Academic Focus","A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties","Inclusion Criteria:\n\n* Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe\n* Estimated IQ of 80 or greater\n* Between 11-17 years of age\n\nExclusion Criteria:\n\n* Presence of suicidality\n* Presence of psychotic disorders\n* Visual or hearing impairment\n* Presence of severe depression",true,"ALL","11 Years","17 Years",{"count":20,"type":21},155,"ESTIMATED","INTERVENTIONAL",[24],"NA","This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.",[27,28,29],"ADHD - Combined Type","ADHD Predominantly Inattentive Type","ADHD, Predominantly Hyperactive - Impulsive","RECRUITING","2025-06-16",{"date":33,"type":34},"2025-06-19","ACTUAL",{"date":36,"type":34},"2024-09-01",{"date":38,"type":21},"2026-02-28",{"name":40,"class":41},"NeuroTrainer","INDUSTRY",3,""]